These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29384970)

  • 1. Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis: A meta-analysis.
    Lou S; Wang L; Wang Y; Jiang Y; Liu J; Wang Y
    Medicine (Baltimore); 2017 Dec; 96(52):e9534. PubMed ID: 29384970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials.
    Lou S; Lv H; Li Z; Zhang L; Tang P
    BMJ Open; 2018 Mar; 8(3):e015187. PubMed ID: 29500198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Lou S; Lv H; Yin P; Li Z; Tang P; Wang Y
    Osteoporos Int; 2019 Jan; 30(1):59-70. PubMed ID: 30539271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
    Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
    Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic and antiresorptive therapy for osteoporosis: combination and sequential approaches.
    Cosman F
    Curr Osteoporos Rep; 2014 Dec; 12(4):385-95. PubMed ID: 25341476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.
    Bilezikian JP
    Curr Osteoporos Rep; 2008 Mar; 6(1):24-30. PubMed ID: 18430397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of Parathyroid Hormone Analogues in Combination With Bisphosphonates for the Treatment of Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Li W; Chen W; Lin Y
    Medicine (Baltimore); 2015 Sep; 94(38):e1156. PubMed ID: 26402797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.
    Li M; Ge Z; Zhang B; Sun L; Wang Z; Zou T; Chen Q
    Arch Osteoporos; 2024 Sep; 19(1):89. PubMed ID: 39312040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
    Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
    Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teriparatide in the treatment of osteoporosis.
    Stroup J; Kane MP; Abu-Baker AM
    Am J Health Syst Pharm; 2008 Mar; 65(6):532-9. PubMed ID: 18319498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
    Shen L; Xie X; Su Y; Luo C; Zhang C; Zeng B
    PLoS One; 2011; 6(10):e26267. PubMed ID: 22022584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis.
    Garcés C; García LE
    Maturitas; 2006 Apr; 54(1):47-54. PubMed ID: 16257150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sequential therapy for postmenopausal women with osteoporosis: A PRISMA-compliant meta-analysis of randomized controlled trials.
    Lou S; Lv H; Wang G; Li Z; Li M; Zhang L; Tang P
    Medicine (Baltimore); 2016 Dec; 95(49):e5496. PubMed ID: 27930536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic skeletal therapy for osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
    Cosman F; Nieves JW; Dempster DW
    J Bone Miner Res; 2017 Feb; 32(2):198-202. PubMed ID: 27925287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
    Melek J; Sakuraba A
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic targets for osteoporosis.
    Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
    Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Treatment of Osteoporosis in Elderly People: A Systematic Review and Meta-Analysis.
    Wang QY; Ding N; Dong YH; Wen ZX; Chen R; Liu SY; Liu H; Sheng ZF; Ou YN
    Gerontology; 2021; 67(6):639-649. PubMed ID: 33823511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.